US Stock MarketDetailed Quotes

AVTX Avalo Therapeutics

Watchlist
  • 7.0300
  • -0.4800-6.39%
Close Jan 8 16:00 ET
  • 7.0300
  • 0.00000.00%
Post 19:18 ET
73.56MMarket Cap0.07P/E (TTM)

About Avalo Therapeutics Company

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Rockville, MD.

Company Profile

SymbolAVTX
Company NameAvalo Therapeutics
Listing DateNov 13, 2015
Founded2011
CEODr. Garry A. Neil, M.D.
MarketNASDAQ
Employees19
Fiscal Year Ends12-31
Address540 Gaither Road,Suite 400
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850
Phone1-410-522-8707
Websitehttp://www.avalotx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Garry A. Neil, M.D.
  • Chairman of the Board, President and Chief Executive Officer
  • 1.08M
  • Paul Varki
  • Chief Legal Officer
  • --
  • Dr. Mittie Doyle, F.A.C.R.,M.D.
  • Chief Medical Officer
  • --
  • Christopher Ryan Sullivan
  • Chief Financial Officer and Principal Accounting Officer
  • 607.65K
  • Jennifer Riley
  • Chief Strategy Officer
  • --
  • Dr. June S. Almenoff, F.A.C.P.,M.D.,PhD
  • Independent Director
  • 59.12K
  • Samantha Truex
  • Independent Director
  • --
  • Dr. Jonathan Goldman, M.D.
  • Independent Director
  • --
  • Aaron Kantoff
  • Independent Director
  • --
  • Mitchell Chan
  • Independent Director
  • 60.12K
  • Dr. Gilla Kaplan,PhD
  • Independent Director
  • 60.12K
Heat List
US
Overall
Symbol
Price
% Chg

No Data